The β-adrenergic cascade is severely impaired in heart failure (HF), in part because of a reduction in the activity of the two dominant cardiac adenylyl cyclase (AC) isoforms, AC5 and AC6. Hence, cardiac-directed AC overexpression is a conceivable therapeutic strategy in HF. In this study, we explored the consequences at the cellular and organ level of a cardiac-directed expression of the human AC8 in the transgenic mouse line AC8TG. Unlike AC5 and AC6, which are inhibited by intracellular Ca 2+ , AC8 is stimulated by Ca 2+ -calmodulin. Langendorff perfused hearts from AC8TG mice had a twofold higher left ventricular systolic pressure, a 40% faster heart rate, a 37% faster relaxation, and a 30% higher sensitivity to external Ca 2+ than nontransgenic control mice (NTG). Cell shortening measured in isolated ventricular myocytes developed 22% faster and relaxed 43% faster in AC8TG than in NTG mice. Likewise, Ca 2+ transients measured in fluo-3 AM-loaded myocytes were 30% higher and relaxed 24% faster in AC8TG compared with NTG mice. In spite of the large increase in Ca 2+ transients and contraction, expression of AC8 had no effect on the whole-cell L-type Ca 2+ current (I Ca,L ) amplitude. Moreover, I Ca,L was unchanged even when AC8 was activated by raising intracellular Ca
A denylyl cyclase (AC) is one of the key proteins involved in the autonomic regulation of heart function. Noradrenaline, the main transmitter of the sympathetic nervous system, acting on β-adrenoceptors (βAR), activates Gs proteins, which stimulate AC activity, leading to cAMP production and phosphorylation of several substrate proteins via activation of cAMP-dependent protein kinase (PKA) (26). Hence, phosphorylation via PKA of L-type Ca 2+ channels (32) , phospholamban (30), myofibrillar protein troponin I (TnI) (40) , and ryanodine receptors (RyR) (35, 38) leads to positive inotropic, lusitropic, and chronotropic effects on the heart.
The β-adrenergic cascade is severely impaired in virtually every form of experimental heart failure and in the human syndrome (36) . Several studies have shown that AC5 and/or AC6 protein level, the dominant AC isoforms expressed in heart, is reduced in this pathology (10, 14) , leading to a decrease in total AC activity (27) , which contributes to a decrease in PKA activity and cardiac contraction.
Recently, cardiac-directed expression of AC5 revealed an increase in basal AC activity and cardiac function that is independent of βAR activation (34) . In addition, the cross-breed between these animals and transgenic mice with a depressed cardiac contractility (G αq overexpressing mice) resulted in animals with a normalized cardiac function (33) . Unlike these AC5 transgenic animals, transgenic mice with a cardiac overexpression of AC6 present a normal basal cardiac function but an increased response to βAR stimulation (11) . The same result was obtained with intracoronary injection of an adenovirus expressing AC6 in pig heart (18) . These data suggest that AC expression might provide a potential means to restore cardiac contractility during heart failure.
Because AC5 and AC6 are the dominant cardiac AC isoforms, it was logical to examine at first how overexpression of these isoforms affects cardiac function. However, this does not exclude the possibility that expression of a noncardiac AC isoform might be beneficial to heart function. One possible advantage of introducing an alien AC gene is that the gene or the expressed protein might escape from the regulatory pathways affecting the activity of its endogenous congeners. Alternatively, the alien AC protein might be addressed to a different location compared with native AC isoforms, leading to a different function. With that in mind, a transgenic mouse expressing in the heart human AC type 8 (AC8) was created (22) . As shown previously (2, 5) , AC8 is essentially expressed in the brain. Also, in this model, AC8 activity is stimulated by Ca 2+ -calmodulin, unlike AC5 or AC6, which are inhibited by intracellular Ca 2+ ([Ca 2+ ] i ) (2, 4, 5) . During β-adrenergic stimulation, the resulting elevation of [Ca 2+ ] i normally inhibits AC5 and AC6, and this supposedly acts as a negative feedback on L-type Ca 2+ channel activity, [Ca 2+ ] i , and cardiac contractility. However, in AC8TG mice, an increase in [Ca 2+ ] i should stimulate AC8 activity, leading to a further increase in [Ca 2+ ] i . Intuitively, such a positive feedback might generate Ca-overload and be deleterious to the animals. However, AC8TG mice present no phenotypic alteration or any sign of cardiomyopathy in spite of a clear increase in cardiac AC and PKA activities (22) . Moreover, noninvasive assessment of cardiac function by echocardiography showed a similar basal cardiac function in AC8TG mice and their control littermates (NTG). However, hemodynamic evaluation after a bilateral vagotomy revealed a higher basal intrinsic contractility in AC8TG vs. NTG mice, indicating that AC8 is indeed functionally active in the heart of these transgenic animals (22) .
In this study, our aim was to examine the adaptive changes taking place within cardiac myocytes as a result of AC8 expression. To do this, we examined the functional properties of cardiac contraction in AC8TG and NTG mice measured at the level of the isolated heart and the isolated ventricular myocyte. Because we suspected that calcium signaling might be affected in this transgenic mouse model, we also measured [Ca 2+ ] i transients and whole-cell L-type Ca 2+ channel current (I Ca,L ) to examine how a cardiac expression of AC8 modifies the influx of Ca 2+ and the sarcoplasmic reticulum (SR) function.
MATERIALS AND METHODS
The investigation conforms with our institution guidelines defined by the European Community guiding principles in the care and use of animals and the French decree n°87/848 of October 19, 1987 . Authorizations to perform animal experiments according to this decree were obtained from the French Ministère de l'Agriculture, de la Pêche et de l'Alimentation (n°7475, May 27, 1997).
Ex vivo physiology
Four-to five-month-old mice were anaesthetized by i.p. injection of pentothal (150 mg/kg). The heart was quickly removed, placed in oxygenated Krebs-Henseleit solution (95% O 2 and 5% CO 2 , pH 7.35) containing low calcium concentration (0.4 mM) and heparin. The aorta was cannulated on a 20-gauge cannula and perfused by the Langendorff method with Krebs-Henseleit solution at constant pressure (75 mmHg). A small homemade latex balloon was inserted in the left ventricle (LV) chamber. The temperature was monitored online and maintained at 37±0.2°C throughout the experiments. All hearts were initially perfused with oxygenated Krebs-Henseleit solution at a perfusate Ca 2+ concentration ([Ca   2+ ] o ) of 1.8 mM, and the LV balloon was progressively inflated to isovolumic condition of work corresponding to an end diastolic pressure (EDP) of 5-8 mmHg. The water-filled balloon was connected to a pressure transducer (Statham gauge Ohmeda, Bilthoven, Holland) for continuous measurement of LV systolic pressure (LVSP) on a paper recorder (Astro-Med, West Warrick, UK). Contractile parameters were measured online by programming a PC-compatible 486/50 microcomputer in Assembly language (Borland) to determine heart rate (HR), LVSP, rate-pressure product (RPP=LVSP×HR, used as an index of contractility), EDP, and the following kinetic parameters: time to peak of contraction (t tp ), ] o (1 mM). In this case, the hearts were stimulated at 680 bpm via platinum wires (stimulator HSE, Hugo Sachs Electronics, March-Hugstetten, Germany). Ten minutes of equilibration in isovolumic working conditions were imposed before beginning the experiment.
Preparation of mouse ventricular myocytes
Ventricular myocytes were isolated from the hearts of NTG and AC8TG mice as previously described (37) . Three-to four-month-old animals were anaesthetised by i.p. injection of pentothal (150 mg/kg), and the heart was quickly removed and placed into a cold Ca 2+ -free Tyrode's solution. The aorta was cannulated, and the heart was perfused with an oxygenated Ca 2+ -free Tyrode's solution for 3-5 min, using retrograde Langendorff perfusion at 37°C. For enzymatic dissociation, the heart was perfused with Ca 2+ -free Tyrode's solution containing collagenase D and protease XXIV for 10 min. Then, the heart was removed and placed in a dish containing 0.2 mM Ca 2+ -Tyrode's solution. The ventricles were separated from atria, cut in small pieces, and triturated with a pipette to disagregate myocytes. Ventricular cells were filtered on gauze and allowed to sediment by gravity for 10 min. The supernatant was removed, and cells were suspended in 0.5 mM Ca 2+ -Tyrode's solution. The procedure was repeated, and the cells were suspended in 1 mM Ca 2+ -Tyrode's solution. The cells were stored at room temperature until use.
Measurement of cell shortening
Free-load cell shortening was measured in ventricular cardiomyocytes from NTG and AC8TG mice. The cells were electrically stimulated by external platinum electrodes placed in the bath around the cell. All images of the contracting myocyte were recorded at 200 frame/s, with an intensified high-speed Lhesa CCD camera (Lheritier SA, Cergy-Pontoise, France) and acquired on PC computer. The time course of the change in cell length was extracted off-line by tracing the cell ends in line-profile images. Myocyte shortening was calculated as the percent change in myocyte length at any given time with respect to the length at rest. In addition, the time to peak of contraction (t peak ), that is, the time interval between electrical stimulation and maximal shortening, and the time for half relaxation (t 50 ), that is, the time interval between peak and halfmaximal recovery, were calculated from the recordings.
Measurement of [Ca

2+ ] i transients
To detect [Ca 2+ ] i transients, we used the fluorescent calcium indicator fluo-3 acetoxymethyl ester (fluo-3 AM, Molecular Probes, Leiden, The Netherlands). Myocytes were incubated with 10 µM fluo-3 AM (dissolved in dimethyl sulfoxide [DMSO]) for 15 min. Then, the cells were washed in buffer solution for 30 min to allow sufficient time for deesterification. Subsequently, the cells were electrically stimulated by external platinum electrodes, and the fluorescent signal from the cell was monitored at a wavelength of 530 nm with an excitation wavelength of 488 nm. All images were acquired with the intensified high-speed Lhesa CCD camera and recorded on a PC microcomputer. [Ca 2+ ] i transients were expressed as F/F 0 , where F is the mean fluorescence of the cell at any given time and F 0 is the mean fluorescence at rest.
L-type Ca
2+ channel current measurement
The whole-cell configuration of the patch-clamp technique was used to record L-type Ca 2+ channel current (I Ca,L ). For routine I Ca,L measurements, the cells were depolarized every 8 s from a holding potential of -50 mV to 0 mV for 400 ms. At this holding potential, fast Na + current and T-type Ca 2+ current were inactivated. External and internal (pipette) solutions contained Cs + instead of K + to eliminate K + currents. The electrical resistance of the patch pipette varied between 0.5 and 1.2 MΩ. All experiments were done at room temperature. A challenger VM (Kinetic, Atlanta, GA) generated voltage-clamp protocols. The currents were measured by a patch-clamp amplifier (Biologic RK 400, Claix, France), filtered at 3 kHz, and sampled at a frequency of 10 kHz. Cells were exposed to different drugs with a system of capillary tubings. The maximal amplitude of I Ca,L was measured as the difference between the peak inward current at 0 mV and the current at the end of 400 ms pulse. Currents were not compensated for capacitive and leak currents. Two mV and 10 ms depolarizations from the holding potential were used to elicit capacitive currents, which were filtered at 10 kHz and sampled at a frequency of 20 kHz. Exponential analysis of these currents led to the estimate of the membrane capacitance and series resistance.
Solutions and drugs
The composition of the initial Krebs-Henseleit solution used for ex vivo experiments was (in mM) NaCl 113, NaHCO 3 -free Tyrode's solution to which 1.4% FCS and 0.2, 0.5, and 1 mM Ca 2+ were added, respectively. The composition of the control external solution for the patch-clamp experiment was (in mM) NaCl 107.1, CsCl 20, HEPES 10, glucose 5, NaHCO 3 4, NaH 2 PO 4 0.8, MgCl 2 1.8, and CaCl 2 1.8. The pH was adjusted to 7.4 with NaOH. Patch pipettes were filled with two types of internal solutions. The first one was a low Ca 2+ solution (3 nM free Ca 2+ concentration) and contained (in mM) CsCl 119.8, HEPES 10, EGTA 5, MgCl 2 4, Na 2 CP 5, CaCl 2 0.0062, Na 2 ATP 3.1, and Na 2 GTP 0.4. The second solution was designed to contain a higher free Ca 2+ concentration (300 nM) and contained (in mM) CsCl 132.8, HEPES 10, EGTA 0.04, MgCl 2 3.8, Na 2 CP 5, CaCl 2 0.03, Na 2 ATP 3.1, and Na 2 GTP 0.4. The pH was adjusted to 7.3 with CsOH in both solutions.
Data analysis
The results are expressed as means ± SE. Student's paired t test was used to test the effect of drugs on NTG and AC8TG hearts. Student's t test for unpaired data or ANOVA followed by a Student-Newman-Keuls test were used to compare NTG and AC8TG mice. A value of P < 0.05 was considered to be statistically significant.
RESULTS
Characteristics of the animals
For 2-month-old AC8TG mice (22) , anatomical examination of 4-to 5-month-old AC8TG and NTG showed no obvious difference between the animals. Body weight (NTG, 30.9±0.4 g; AC8TG, 30.7±0.4 g), tibia length (NTG, 1.8±0.01 cm; AC8TG, 1.8±0.01 cm), dry heart weight (NTG, 30.7±0.6 mg; AC8TG, 31.8±1.8 mg), heart-to-body weight ratio (NTG, 0.99±0.02 mg/g; AC8TG, 1.03±0.06 mg/g) and heart weight-to-tibia length ratio (NTG, 17.2±0.4 mg/cm; AC8TG, 18.0±1.0 mg/cm) were unchanged by transgene expression (NTG mice, n=6; AC8TG mice, n=8).
Influence of AC8 expression on the spontaneous contractility of the heart
Myocardial contractility was assessed at the peak of the pressure volume curve after progressive inflation of the LV balloon. The coronary flow was similar in NTG (2.8±0.2 ml/min, n=6) and AC8TG mice (3.4±0.5 ml/min, n=7) at [Ca 2+ ] o =1.8 mM.
Baseline spontaneous cardiac function was compared in 13 AC8TG and 12 NTG mice (Fig. 1) . LVSP was twofold higher in AC8TG than in NTG (110± 9mmHg vs. 56±5 mmHg, P<0.001); spontaneous HR was significantly faster in AC8TG than in NTG hearts (481±21 bpm vs. 337± 15 bpm, P<0.001); and EDP was similar. As a result, the rate-pressure product (RPP) was nearly threefold higher in AC8TG compared with NTG mice, demonstrating that specific cardiac expression of AC8 enhanced basal spontaneous function of the isolated heart. Because AC8 activity is stimulated by Ca ] o from 0.5 to 2.5 mM resulted in a dose-dependent increase in LVSP in both AC8TG and NTG hearts ( Fig. 2A) without alteration in HR (Fig. 2B) ] o , determined by curve fitting on individual hearts using the Hill equation (Fig. 2A) , was significantly lower in AC8TG (1.05±0.07 mM) than in NTG mice (1.51±0.12 mM, P<0.05).
Influence of AC8 expression on the contractility of the paced heart
Because cardiac expression of AC8 results in a strong acceleration of HR, which in itself might affect the contractile properties of the hearts, the following experiments were performed under pacing at 680 bpm in six NTG and six AC8TG mice. The measurements were performed at 1 mM [Ca 2+ ] o . At this concentration, cardiac work was not yet at maximum in both types of mice. Under this condition, the coronary flow was 2.9 ± 0.4 ml/min and 3.3 ± 0.3 ml/min in NTG and AC8TG mice, respectively.
Under pacing conditions, AC8TG mice still developed a significantly higher LVSP than did NTG mice (Table 1) . A detailed analysis of the kinetics of contraction and relaxation revealed that the maximal rate of contraction, measured as the maximal value of +d(LVSP)/dt, was significantly higher in AC8TG mice (3613±483 mmHg/s) compared with NTG mice (1392±38 mmHg/s, P<0.01). However, this difference solely resulted from the increase in LVSP. When normalized to LVSP, both the maximal rate of contraction [+d(LVSP)/dt/LVSP] and the time to peak of contraction (t tp ) were similar in both groups of mice (respectively: 52±1 s -1 and 26±1 ms in NTG; 56±3 s -1 and 24±1 ms in AC8TG mice). All relaxation parameters were markedly affected by AC8 expression. Indeed, the maximal rate of relaxation [-d(LVSP)/dt] was about threefold higher in AC8TG mice (-2508±318 mmHg/s) compared with NTG mice (-788±73 mmHg/s). However, by contrast to the onset of contraction, the rate of relaxation was still ∼26% higher when normalized to LVSP [-d(LVSP)/dt/LVSP: -39±3 s -1 in AC8TG mice; -29±1 s -1 in NTG mice]. Likewise, the half-time of relaxation (t R1/2 ) was 37% shorter in AC8TG mice (20±1 ms) compared with NTG mice (32±2 ms). Thus, cardiac AC8 expression induced a marked acceleration of relaxation.
Measurement of cell shortening
To determine whether AC8 cardiac expression also modified basal contractility of ventricular myocytes, we measured cell shortening in isolated ventricular myocytes from AC8TG and NTG mice. Figure 3A shows that the amplitude of cell shortening was not statistically different between NTG and AC8TG mice (18.7±2%, n=8 in NTG mice and 21.3±0.9%, n=11 in AC8TG mice). This was because the myocytes were not attached at the bottom of the dish, so that the cells contracted free of load and shortening was maximal in both cases. However, the time to peak (t peak ) was significantly shorter (159±10 ms, n=8, in NTG mice and 126±7 ms, n=11, in AC8TG mice, P<0.01) and the time for half relaxation (t 50 ) was much faster in transgenic myocytes (160±24 ms, n=8, in NTG mice and 108±10 ms, n=11, in AC8TG mice, P<0.05) (see Fig. 3B and 3C ). On average, t 50 and the t peak were reduced by 43% and 22%, respectively, in AC8TG mice.
Measurement of [Ca
2+ ] i transients
Because contraction and relaxation kinetics are largely dependent on Ca 2+ release from and uptake into the SR, we measured [Ca 2+ ] i transients in AC8TG and NTG myocytes, using the fluorescent Ca 2+ indicator fluo-3 AM. As shown in Figure 4A , [Ca 2+ ] i transients were larger in amplitude in AC8TG than in NTG mice (peak F/Fo was 2.1±0.1, n=16, and 2.7±0.2, n=24, respectively, in NTG and AC8TG mice, P=0.02). Moreover, a kinetic analysis showed that [Ca 2+ ] i transient developed with a similar time course in AC8TG and NTG mice but relaxed substantially faster in AC8TG (Fig. 4B and 4C) . Indeed, half maximal relaxation of [Ca 2+ ] i transient (t 50 ) was reduced from 173.8±13.8 ms, n=16, in NTG to 140±9.6 ms, n=24, in AC8TG mice (P<0.05).
Calcium current measurements
Because the amplitude of cardiac contraction is largely dependent on the activity of L-type Ca 2+ channels, which initiate the calcium-induced calcium-release mechanism, we examined how cardiac expression of AC8 affects I Ca,L in isolated ventricular myocytes. After breaking the membrane patch and reaching the whole-cell configuration, cell membrane capacitance (C m ) was measured in AC8TG and NTG myocytes. Both mice had a similar C m (177±9 pF, n=16, in NTG; 175±7 pF, n=18, in AC8TG), indicating that on average the cells had a similar size and confirming the absence of cell hypertrophy in AC8TG mice. The cells were then voltageclamped at a holding potential of -50 mV, and I Ca,L was recorded in control solution during 400 ms depolarizations to 0 mV. Figure 5A shows two representative traces of I Ca,L recorded from NTG and AC8TG ventricular myocytes. Averaged I Ca,L amplitudes were 766±59 pA, n = 18, in AC8TG myocytes and 911±128 pA, n = 16, in NTG myocytes and were not statistically different (see Fig. 5B ). Likewise, when normalized to cell membrane capacitance, I Ca,L current density was similar in AC8TG and NTG ventricular myocytes: 5.2±0.4 pA/pF, n=18, in AC8TG vs. 4.2±0.4 pA/pF, n=16, in NTG (see Fig. 5C ). Thus, AC8 expression did not modify basal I Ca,L amplitude and current density at 0 mV. In addition, as shown in Figure 5D , AC8 expression did not modify the voltage dependence of peak I Ca,L .
In these experiments, I Ca,L was measured with a patch pipette containing a high (5 mM ] i was estimated to be ∼300 nM. Reducing the Ca 2+ buffering capacity of the pipette solution led to an increase in basal I Ca,L amplitude. However, the current amplitudes were still similar in AC8TG and NTG mice (1170.5±123.9 pA, n=20, for NTG vs. 1405.3±140.1 pA, n=22, for AC8TG).
In another set of experiments, the effect of increasing the stimulation frequency under voltageclamp conditions was tested on ventricular myocytes from NTG and AC8TG hearts. The rationale behind these experiments was that increasing the stimulation frequency should lead to a progressive increase of [Ca 2+ ] i in a submembrane compartment, and this may result in a stimulation of cAMP synthesis through Ca 2+ activation of AC8 in AC8TG mice, but not in NTG mice. The cells were depolarized at 0 mV during 40 ms from a -50 mV holding potential, and the stimulation frequency was progressively increased from 0.125 Hz (control frequency) to 8 Hz in twofold steps, with 10 depolarizations applied at each frequency. As shown in Figure 6 , increasing the stimulation frequency elicited a similar negative staircase phenomenon on I Ca,L amplitude, with no significant difference between the two animal models. Altogether, these experiments demonstrate that cardiac-directed expression of AC8 leads to enhanced cardiac function that does not involve an increase in I Ca,L .
DISCUSSION
A transgenic mouse with a cardiac-specific expression of human AC8 isoform has been created (22) . AC8 is normally present in the brain; absent in the heart; and unlike endogenous cardiac AC5 and AC6, which are inhibited by Ca 2+ , at least in vitro; AC8 stimulated by Ca 2+ -calmodulin (2, 5, 22) . In this study, we show that 1) cardiac-specific expression of AC8 is associated with a strong enhancement of ex vivo basal cardiac function and an increased sensitivity of cardiac contraction to [Ca 2+ ] o ; 2) at the level of the isolated ventricular myocyte, cell shortening developed faster and relaxed faster in AC8TG than in NTG mice; 3) [Ca 2+ ] i transient amplitude was enhanced and its decay was faster in AC8TG vs. NTG mice, which indicates a faster reuptake of Ca 2+ by the SR; and 4) in spite of the large increase in Ca 2+ transients and contraction, I Ca,L amplitude was unchanged in AC8TG, even when AC8 was activated by raising [Ca 2+ ] i .
Myocardial overexpression of endogenous or exogenous AC isoforms leads to different cardiac phenotypes. In AC6 transgenic mice, cAMP production is not altered under basal conditions but is largely enhanced upon β-adrenergic stimulation (11), whereas in AC8TG (22) and AC5 transgenic mice (34) , basal AC activity is increased. In AC8TG mice, echocardiography assessment showed no modification in cardiac function (22) , whereas basal contraction was enhanced under in vivo (22) and ex vivo recordings (as shown by this study). Increasing AC6 levels are associated with an enhancement of in vivo basal cardiac contraction and HR (measurement performed with a bilateral vagotomy), which are not modified under echocardiography and ex vivo recordings (11) . The heterogeneity of these results suggests that cardiac function does not simply depend on the global AC activity and cAMP level but that each AC isoform could provide a specific modulation of myocardial contraction, for instance, different localization at the cell membrane leading to different interaction with subcellular compartments (16) .
Myocardial contractility is critically dependent on Ca 2+ influx via the L-type Ca 2+ channels (32), which suggests a possible alteration of I Ca,L to explain the strong increase in cardiac function observed in AC8TG mice. To our surprise, I Ca,L current amplitude was similar in ventricular myocyte of AC8TG and NTG mice. Moreover, increasing intracellular Ca 2+ concentration by either reducing the Ca 2+ buffering capacity of the pipette solution or by increasing the stimulation frequency did not generate any difference between I Ca,L amplitude in NTG and AC8TG mice. This finding led us to conclude that the observed increase in contractility in AC8TG mice is not due to a stimulation of L-type Ca 2+ channel activity. In fact, it seems as if there was no crosstalk between AC8 and Ca 2+ channels in AC8TG mice: cAMP production by AC8 does not lead to Ca 2+ channel phosphorylation, and Ca 2+ influx via I Ca,L does not lead to AC8 stimulation. It is likely that adaptive changes occurred in AC8TG mice to avoid a positive feedback between AC8 and intracellular Ca Although cAMP produced by AC8 appears not to be accessible to Ca 2+ channels, it clearly is available for other elements of the EC coupling. Similar results have been reported for the transgenic mouse (TG4) overexpressing the β 2 -adrenoreceptor (β 2 AR) (25, 29, (41) (42) (43) . The TG4 mouse heart expresses a large amount of constitutively active β 2 AR, which leads to an increase in basal AC activity. However, the cardiac contractility is enhanced without any alteration in basal I Ca,L (43) , suggesting a compartmentation of β 2 AR-mediated signaling (16, 31, 43) .
If the increased cardiac contractility in AC8TG mice is not due to an increase in Ca 2+ influx via L-type Ca 2+ channels, what other mechanism(s) might be involved? For several reasons, we believe that an enhanced SR function might explain the functional alterations observed in AC8TG mice. First, in vivo hemodynamic studies showed an acceleration in the cardiac contractile parameters in AC8TG vs. NTG mice (22) . Second, in this study, using the ex vivo Langendorff perfused heart model, we found a marked acceleration in the contractile relaxation in AC8TG mice compared with NTG mice. Third, at the level of the single ventricular myocyte, both cell shortening and calcium transient relaxed much faster in AC8TG than in NTG mice. Thus, cardiac-directed expression of AC8 might specifically accelerate Ca 2+ re-uptake into the SR without affecting Ca 2+ influx into the cell. This could be achieved by an increase in the total amount of SR Ca 2+ -ATPase (SERCA), an alleviated inhibitory effect of phospholamban (PLB), its key regulator protein (30), due to PKA phosphorylation, or both. Interestingly, knockout mice lacking PLB develop a very similar phenotype to the AC8TG mice: an increased cardiac contraction and relaxation (13, 23, 24) and, at the cell ventricular level, a shorter time to peak, a faster relaxation phase of contraction, and a faster decay of Ca 2+ transient (19, 20) . In TG4 mice, in vivo cardiac relaxation is enhanced and associated with a reduction of PLB (28) . Consistent with these studies, AC8 cardiac expression could affect the content and/or phosphorylation of PLB, leading to an enhanced cardiac contraction and relaxation as observed in our model. AC8TG mice might thus provide a unique model of cAMP compartmentation, whereby cAMP produced by AC8 specifically activates Ca 2+ uptake into the SR without increasing Ca 2+ influx at the sarcolemma. However, other mechanisms cannot be excluded, such as an enhancement of myofilament Ca 2+ sensitivity due to PKA-phosphorylation of troponin I (26, 39, 40) , an overexpression of SERCA2a, the cardiac SERCA isoform, or βARK inhibitor, which have been shown independently to increase cardiac contractility (12, 17) .
Several transgenic models overexpressing a protein involved in the β-adrenergic signaling cascade develop a cardiomyopathy (6, 36) . Overexpression of β 2 AR leads to a constitutive increase in cardiac contractility in adult TG4 mice (1, 25) , but old TG4 mice with a high level of β 2 AR expression develop a cardiomyopathy (8, 21) . Moreover, ischemia and heart failure have more deleterious consequences in TG4 than in NTG animals (3, 7) . Increasing β 1 -receptor or Gα s protein levels leads to an increase in heart rate, a decrease in cardiac contractility, and a progressive development of hypertrophy and heart failure (9, 15) . Surprisingly, AC8TG mice do not show any detrimental consequences of cardiac expression of AC8, at least up to the age of 14 months (N. Defer, unpublished data). Unlike AC6 transgenic mice, which need to be activated by the β-adrenergic pathway to improve cardiac function (11), AC8TG mice develop an enhanced cardiac function under basal conditions. Thus, cardiac expression of AC8 might provide a means to increase heart function even when the β-adrenergic signaling cascade is down-regulated at the receptor level, as during heart failure. Additional experiments, such as gene transfer in adult animal models of heart failure, are required to examine whether cardiac-directed expression of AC8 could provide a potential means for the treatment of heart failure. ] o . A) left ventricular systolic pressure (LVSP); B) heart rate (HR) and C) rate-pressure product (RPP) were measured in NTG (empty bars) and AC8TG mice (filled bars) when all parameters were stable and under spontaneous beating conditions. The bars are means ±SE. NTG, n=13; AC8TG, n=12. ***P <0.0001. Whole-cell I Ca,L were recorded in NTG and AC8TG myocytes at six increasing stimulation frequencies: 0.25, 0.5, 1, 2, 4, and 8 Hz. The currents were elicited upon a 40 ms depolarization to 0 mV from a holding potential of -50 mV. At each frequency, 10 successive pulses were applied before applying a twofold higher frequency. The I Ca,L amplitudes were normalized to the amplitude of the current at the control stimulation frequency (0.125 Hz). The points indicate the means ±SE from three NTG (○) and three AC8TG myocytes (▲).
